Chemical name: (17β)-3-Oxoandrost-4-en-17-yl propanoate
Formula: C22H32O3
Anabolic activity index: 100% (reference drug)
Androgenic activity index: 100% (reference drug)

SUSTANON 250 10ml VIAL – HILMA BIOCARE

Description: SUSTANON 250 is a medication manufactured by Hilma Biocare. It is available in a 10ml vial and is formulated as an injectable solution. SUSTANON 250 is a testosterone blend consisting of four testosterone esters: testosterone decanoate, testosterone isocaproate, testosterone phenylpropionate, and testosterone propionate.

Active Substances:

1. Testosterone Decanoate: A long-acting ester with a slow release rate.
2. Testosterone Isocaproate: An intermediate-acting ester with a moderate release rate.
3. Testosterone Phenylpropionate: A shorter-acting ester with a faster release rate than decanoate.
4. Testosterone Propionate: A short-acting ester with a rapid release rate.

Uses: SUSTANON 250 is primarily prescribed for testosterone replacement therapy (TRT) in men with hypogonadism (low testosterone levels) or androgen deficiency. It may also be used in hormone replacement therapy (HRT) for transgender men, and in certain cases of delayed puberty in adolescent males.

How to Use: SUSTANON 250 is administered via intramuscular injection. The dosage and frequency of administration depend on the individual patient’s medical condition, testosterone levels, and response to treatment. Administration should be performed by a healthcare professional according to proper injection techniques.

Storage Conditions: SUSTANON 250 vials should be stored at room temperature, away from moisture, heat, and direct sunlight. It is important to keep the medication out of reach of children and pets.

Mechanism of Action: SUSTANON 250 provides a sustained release of testosterone due to the combination of different esters with varying release rates. After injection, testosterone is gradually released into the bloodstream, maintaining stable testosterone levels over an extended period. Testosterone replacement therapy helps alleviate symptoms associated with low testosterone levels, such as fatigue, reduced libido, and loss of muscle mass.

Precautions:

• Patients with a history of prostate cancer, breast cancer, or cardiovascular disease should use SUSTANON 250 cautiously and under the supervision of a healthcare provider.
• Regular monitoring of testosterone levels and clinical response is important during treatment.

Contraindications: SUSTANON 250 is contraindicated in individuals with hypersensitivity to testosterone or any component of the formulation. It should not be used in women, particularly pregnant or breastfeeding women, due to the risk of masculinization and potential harm to the fetus or nursing infant.

Drug Interactions: SUSTANON 250 may interact with certain medications, particularly anticoagulants, insulin, and oral hypoglycemic agents. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.

Side Effects: Common side effects of SUSTANON 250 may include acne, oily skin, hair loss, increased body hair growth, and mood changes. Other potential side effects include fluid retention, gynecomastia (enlarged breast tissue in men), and changes in libido. Serious adverse reactions such as liver toxicity, cardiovascular events, and prostate enlargement may occur but are rare.

Patients should consult their healthcare provider for personalized advice and information regarding SUSTANON 250, including its uses, dosage, and potential side effects.